Orthofix Medical Inc. (OFIX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 300M 600M 900M Q3 '21: 457M Q4 '21: 464.5M Q1 '22: 465.3M Q2 '22: 462M Q3 '22: 463.5M Q4 '22: 460.7M Q1 '23: 529.5M Q2 '23: 598.4M Q3 '23: 668.5M Q4 '23: 746.6M Q1 '24: 760M Q2 '24: 771.6M Q3 '24: 784.2M Q4 '24: 799.5M Q1 '25: 804.5M Q2 '25: 809M Q3 '25: 818.1M Q4 '25: 822.3M Q1 '26: 825.4M Q2 '26: 833.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 250M 500M 750M Q3 '21: 346.3M Q4 '21: 349.6M Q1 '22: 348M Q2 '22: 340.5M Q3 '22: 339.8M Q4 '22: 337.2M Q1 '23: 369.4M Q2 '23: 402.5M Q3 '23: 438.8M Q4 '23: 486.3M Q1 '24: 503.2M Q2 '24: 518.4M Q3 '24: 533.7M Q4 '24: 545.9M Q1 '25: 540.3M Q2 '25: 545M Q3 '25: 558.5M Q4 '25: 566M Q1 '26: 583.9M Q2 '26: 594.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

-150M -100M -50M 0 50M 100M 150M Q3 '21: 4.7M Q4 '21: -8.3M Q1 '22: -8.5M Q2 '22: -6.1M Q3 '22: -11.6M Q4 '22: -13.3M Q1 '23: -69.9M Q2 '23: -113.2M Q3 '23: -131.8M Q4 '23: -139.1M Q1 '24: -108.7M Q2 '24: -97M Q3 '24: -91.5M Q4 '24: -84.6M Q1 '25: -104.2M Q2 '25: -95.3M Q3 '25: -93.4M Q4 '25: -81.4M Q1 '26: -47M Q2 '26: -39.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-180M -120M -60M 0 60M 120M 180M Q3 '21: -14.9M Q4 '21: -38.4M Q1 '22: -37M Q2 '22: -37M Q3 '22: -45.5M Q4 '22: -19.7M Q1 '23: -76.2M Q2 '23: -118.1M Q3 '23: -136.3M Q4 '23: -151.4M Q1 '24: -126.5M Q2 '24: -120.5M Q3 '24: -119M Q4 '24: -126M Q1 '25: -143.1M Q2 '25: -123.7M Q3 '25: -119.1M Q4 '25: -92.2M Q1 '26: -60M Q2 '26: -61.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 90M 180M 270M Q3 '21: 110.7M Q4 '21: 114.9M Q1 '22: 117.3M Q2 '22: 121.5M Q3 '22: 123.7M Q4 '22: 123.5M Q1 '23: 160.1M Q2 '23: 196M Q3 '23: 229.6M Q4 '23: 260.4M Q1 '24: 256.9M Q2 '24: 253.3M Q3 '24: 250.6M Q4 '24: 253.6M Q1 '25: 264.3M Q2 '25: 264M Q3 '25: 259.5M Q4 '25: 256.3M Q1 '26: 241.4M Q2 '26: 239.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

-60M -40M -20M 0 20M 40M 60M Q3 '21: 29M Q4 '21: 18.5M Q1 '22: 8.3M Q2 '22: 5.6M Q3 '22: -2.1M Q4 '22: -11.5M Q1 '23: -37.8M Q2 '23: -38.5M Q3 '23: -36.7M Q4 '23: -45.8M Q1 '24: -30.3M Q2 '24: -15.8M Q3 '24: -4.6M Q4 '24: 25.8M Q1 '25: 26M Q2 '25: 28.6M Q3 '25: 29.4M Q4 '25: 33.3M Q1 '26: 34.1M Q2 '26: 16.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-120M -80M -40M 0 40M 80M 120M Q3 '21: 13.6M Q4 '21: 690K Q1 '22: -10.4M Q2 '22: -14.2M Q3 '22: -24.5M Q4 '22: -32.9M Q1 '23: -65.4M Q2 '23: -72.6M Q3 '23: -87.6M Q4 '23: -106M Q1 '24: -89.7M Q2 '24: -72.1M Q3 '24: -44.4M Q4 '24: -8M Q1 '25: -3.9M Q2 '25: 951K Q3 '25: -2.9M Q4 '25: -1.3M Q1 '26: -4.4M Q2 '26: -27.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15M 30M 45M Q1 '20: 19.3M Q2 '20: 19.2M Q3 '20: 19.4M Q1 '21: 19.5M Q2 '21: 19.9K Q3 '21: 19.8K Q1 '22: 19.9K Q2 '22: 20.1K Q3 '22: 20.1K Q1 '23: 35.7K Q2 '23: 36.8K Q3 '23: 37.2M Q1 '24: 37.7M Q2 '24: 38M Q3 '24: 38.5M Q1 '25: 39.2M Q2 '25: 39.5M Q3 '25: 39.8M Q1 '26: 40.5M Q2 '26: 40.9M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q3 '18: 0.33 Q4 '18: 0.71 Q1 '19: 0.49 Q2 '19: 0.41 Q3 '19: -1.66 Q4 '19: -1.52 Q1 '20: -0.25 Q2 '20: -1.18 Q3 '20: 1.20 Q4 '20: 0.13 Q1 '21: -1.49 Q2 '24: -3.19 Q3 '24: -3.13 Q4 '24: -3.29 Q1 '25: -3.69 Q2 '25: -3.17 Q3 '25: -3.03 Q4 '25: -2.33 Q1 '26: -1.50 Q2 '26: -1.53 Q4 '18 Q3 '19 Q2 '20 Q1 '21 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.